Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

NCT02950870 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis, C Virus

Interventions

DRUG: Ombitasvir-Paritaprevir-Ritonavir
DRUG: Dasabuvir
DRUG: Ribavirin

Sponsor

University of Modena and Reggio Emilia